triazoles has been researched along with colistin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cavanagh, J; Huigens, RW; Melander, C; Rogers, SA | 1 |
Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J | 1 |
Bidaud, AL; Dannaoui, E; Schwarz, P | 1 |
Bange, G; Bidaud, AL; Dannaoui, E; Nikolskiy, I; Schwarz, P; Sommer, F | 1 |
4 other study(ies) available for triazoles and colistin
Article | Year |
---|---|
Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteria; Biofilms; Calcium Chloride; Chlorides; Colistin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Drug Synergism; Enterococcus faecium; Erythrocytes; Escherichia coli; Humans; Imidazoles; Magnesium; Manganese Compounds; Methicillin-Resistant Staphylococcus aureus; Novobiocin; Staphylococcus epidermidis; Tobramycin; Triazoles | 2010 |
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
In vitro synergy of isavuconazole in combination with colistin against Candida auris.
Topics: Agar; Antifungal Agents; Candida; Candidiasis; Colistin; Colony Count, Microbial; Drug Synergism; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2020 |
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Colistin; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles | 2022 |